Sr. Director, Marketing GIST job in Waltham
Share
Tweet
LinkedIn
Waltham, Massachusetts - MA Cogent Biosciences
| Job Ref: | 4087658009 |
| Employer: | Cogent Biosciences |
| Category: | General Marketing |
| Salary and Benefits: | USD 250,000.00 - 290,000.00 per year |
Location | |
| State: | Massachusetts - MA |
| City: | Waltham |
| Map: | United States, Massachusetts , Waltham (Show on map) |
Description | |
|
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's. The company's lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS. Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights. The Role: This position will report to the Vice President of Marketing and offers an extraordinary opportunity for individuals interested in joining a company on the verge of it's first product launch with outstanding data in rare disease and oncology indications. This is a rare opportunity to lead the launch of Bezuclastinib in 2L Gastrointestinal Stromal Tumor (GIST) indication. Bezuclastinib represents the most transformative advancement in GIST in the last 20 years. The Senior Director of Marketing is recognized as an internal expert in GIST disease, market and promotions. The individual is responsible for developing brand strategy for the GIST indication and leading a comprehensive HCP marketing program for bezuclastinib in the US. The individual will lead HCP marketing initiatives and work closely with the cross-functional team to develop and execute marketing strategies that promote brand and company goals. As an in-house expert on HCP marketing and GIST, this person will provide leadership and guidance to the current team and cross functional partners on marketing activities, strategic and competitive planning, strategic and tactical plan execution, segmented marketing capabilities/execution, digital and omni-channel marketing to HCPs. This individual will ensure tactics and capabilities provide ongoing measurement and optimization at each stage and that resources (dollars and FTE effort) are aligned. The successful candidate will contribute in-depth marketing expertise, work closely with internal stakeholders up to executive levels and external partners (including creative agencies, operational partners, medical and diagnostics teams, analytics teams), with the capacity to develop a tactical plan with budget, resourcing, and implementation plan to support the needs of the business. Responsibilities:
Qualifications:
Salary Range: $250,000 - $290,000 USD Target Bonus: 25% Exact compensation will vary based on skills, experience, and location. Our Locations Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building. Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent's discovery research organization. Our Offer To You To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits. We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need. | |
ref: (4087658009) 11 days ago
Back to search results
